|
|
|
|
| LEADER |
01823nam a22004817i 4500 |
| 001 |
MUB01006413273 |
| 003 |
CZ BrMU |
| 005 |
20180319095107.0 |
| 008 |
180316t20172017xxu||||| |||||||||||eng d |
| STA |
|
|
|a POSLANO DO SKCR
|b 2018-05-14
|
| 020 |
|
|
|a 978-0-9963462-4-5
|
| 040 |
|
|
|a BOD035
|b cze
|e rda
|
| 072 |
|
7 |
|a 615
|x Farmacie. Farmakologie
|2 Konspekt
|9 14
|
| 080 |
|
|
|a 615:338.45
|2 MRF
|
| 080 |
|
|
|a 615.2/.3
|2 MRF
|
| 080 |
|
|
|a 615.32/.35:60
|2 MRF
|
| 245 |
0 |
0 |
|a PAREXEL biopharmaceutical R&D statistical sourcebook 2017/2018 /
|c edited by Mark P. Mathieu
|
| 264 |
|
1 |
|a Waltham, MA :
|b PAREXEL International Corporation,
|c [2017]
|
| 264 |
|
4 |
|c ©2017
|
| 300 |
|
|
|a xxv, 455 stran :
|b ilustrace
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a bez média
|b n
|2 rdamedia
|
| 338 |
|
|
|a svazek
|b nc
|2 rdacarrier
|
| 650 |
0 |
7 |
|a bioléčiva
|7 ph503045
|2 czenas
|
| 650 |
0 |
7 |
|a farmaceutický průmysl
|7 ph120140
|2 czenas
|
| 650 |
0 |
7 |
|a léky
|7 ph115196
|2 czenas
|
| 650 |
0 |
9 |
|a biopharmaceuticals
|2 eczenas
|
| 650 |
0 |
9 |
|a drugs
|2 eczenas
|
| 650 |
0 |
9 |
|a pharmaceutical industry
|2 eczenas
|
| 655 |
|
7 |
|a statistické přehledy
|7 fd133587
|2 czenas
|
| 655 |
|
9 |
|a statistical surveys
|2 eczenas
|
| 700 |
1 |
|
|a Mathieu, Mark P.
|4 edt
|
| 710 |
2 |
|
|a PAREXEL International Corporation
|4 pbl
|
| CAT |
|
|
|a VASICEK
|b 02
|c 20180316
|l MUB01
|h 1337
|
| CAT |
|
|
|a VASICEK
|b 02
|c 20180319
|l MUB01
|h 0951
|
| CAT |
|
|
|c 20180514
|l MUB01
|h 1105
|
| CAT |
|
|
|c 20210614
|l MUB01
|h 1027
|
| CAT |
|
|
|c 20210614
|l MUB01
|h 2014
|
| CAT |
|
|
|a BATCH
|b 00
|c 20210724
|l MUB01
|h 1300
|
| LOW |
|
|
|a POSLANO DO SKCR
|b 2018-05-14
|
| 994 |
- |
1 |
|l MUB01
|l MUB01
|m BOOK
|1 KUK
|a Knihovna univ. kampusu
|2 DLOVY
|b KUK - dlouhodobé
|5 3285015129
|8 20180319
|f 77
|f Dlouhodobá
|g 2018-3
|r 20180319
|s kup
|
| AVA |
|
|
|a MED50
|b KUK
|c KUK - dlouhodobé
|e unavailable
|t Není k dispozici
|f 1
|g 1
|h N
|i 0
|j DLOVY
|
